These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6262147)

  • 21. [Studies on the reactivity of macrophages to enterovirus infections. 3. Reproduction of wild, attenuated and intermediate strains of Poliomyelitis virus in macrophage culture].
    Kańtoch M; Dobrowolska H
    Med Dosw Mikrobiol; 1968; 20(2):207-12. PubMed ID: 4299408
    [No Abstract]   [Full Text] [Related]  

  • 22. Choice of cell substrate for biological products.
    Beale AJ
    Adv Exp Med Biol; 1979; 118():83-97. PubMed ID: 227238
    [No Abstract]   [Full Text] [Related]  

  • 23. Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.
    Crainic R; Horodniceanu F; Barme M
    Dev Biol Stand; 1980; 46():275-9. PubMed ID: 6245003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propagation of poliovirus in microcarrier cultures of three monkey kidney cell lines.
    Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J
    J Biol Stand; 1981; 9(2):137-45. PubMed ID: 6263932
    [No Abstract]   [Full Text] [Related]  

  • 25. SV40 and human cancer.
    Hayflick L
    Science; 1997 Apr; 276(5311):337-8. PubMed ID: 9139350
    [No Abstract]   [Full Text] [Related]  

  • 26. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
    Chocarro LB; Manau MV
    Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative sensitivity of a KB cell line and monkey kidney cells in primary culture for the titration of live attenuated poliovirus strains (Sabin)].
    Gaudin OG; Bouguermouh I; Bouguermouh A
    Arch Inst Pasteur Alger; 1972-1973; 50-51():247-50. PubMed ID: 4220155
    [No Abstract]   [Full Text] [Related]  

  • 29. Serially subcultivated cells as substrates for poliovirus production for vaccine.
    von Seefried A; Chun JH
    Dev Biol Stand; 1981; 47():25-33. PubMed ID: 6262151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WHO activities towards the three Rs in the development and control of biological products.
    Milstien J; Grachev V; Padilla A; Griffiths E
    Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart glycosides in poliovirus host cell interaction. I. Effect of digoxin and digitoxin and their aglucons on one step growth curves.
    Koch A; György E
    Acta Microbiol Acad Sci Hung; 1969; 16(2):189-96. PubMed ID: 4313999
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitation of cell DNA in the evaluation of heteroploid cells as substrate for the preparation of killed viral vaccines.
    Crainic R; Horodniceanu F; Barme M
    Intervirology; 1980; 14(5-6):300-9. PubMed ID: 6265401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An avian cell line designed for production of highly attenuated viruses.
    Jordan I; Vos A; Beilfuss S; Neubert A; Breul S; Sandig V
    Vaccine; 2009 Jan; 27(5):748-56. PubMed ID: 19071186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Preliminary experiments with passage variants.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV
    Acta Virol; 1968 May; 12(3):193-202. PubMed ID: 4385148
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cell-containing substrates and vaccine production].
    Majer M
    Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenicity of trypsin treated type 2 and type 3 poliovirus in rats.
    Kersten GF; Lantinga M; Hazendonk T; Beuvery EC
    Biologicals; 1995 Jun; 23(2):179-83. PubMed ID: 7546661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propagation of large quantities of poliovirus in human lymphoblastoid cells grown in a serum-free medium.
    Bjare U
    J Virol Methods; 1984 Nov; 9(3):259-68. PubMed ID: 6097596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of influenza virus replication in Vero and MDCK cell lines.
    Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
    J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of inactivated poliovirus vaccine derived from Sabin strains.
    Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
    Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.